Recap: Adeia Q4 Earnings

Adeia (NASDAQ:ADEA) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM. Here’s what investors…

Adeia (NASDAQ:ADEA) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Adeia beat estimated earnings by 8.0%, reporting an EPS of $0.27 versus an estimate of $0.25.

Revenue was down $16.42 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.12 which was followed by a 4.94% increase in the share price the next day.

Here’s a look at Adeia’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.26 0.22 0.33 0.30
EPS Actual 0.38 0.26 0.48 0.41
Revenue Estimate 90.81M 84.17M 98.97M 101.51M
Revenue Actual 101.40M 83.22M 117.31M 103.29M

To track all earnings releases for Adeia visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue And Provides Corporate Updates; Sees Q4 Revenue $69M-$71M Vs $68.27M Est.; FY23 Revenue $178M-$180M Vs $185.4M Est.; LIVMARLI Net Products Sales Of $141M-143M Expected For 2023

- $186-188 million in total revenue and $178-180 million net product sales expected for 2023, preliminary and unaudited- LIVMARLI net products sales of $141-143 million expected for 2023, representing approximately 89%

MIRM